Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

CanSino Biologics

Market Cap: HK$9.9b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

CSPC Innovation Pharmaceutical

Market Cap: CN¥53.9b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Bonesupport Holding

Market Cap: SEK 15.7b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$120.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Innovent Biologics

Market Cap: HK$155.9b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Akeso

Market Cap: HK$89.6b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

AbbVie

Market Cap: US$441.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$49.3b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Merck

Market Cap: US$308.9b

Operates as a healthcare company worldwide.

AstraZeneca

Market Cap: UK£199.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Idorsia

Market Cap: CHF 1.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.4b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Medexus Pharmaceuticals

Market Cap: CA$161.2m

Operates as a pharmaceutical company in Canada and the United States.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €210.3m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Renata

Market Cap: ৳52.8b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

Aroa Biosurgery

Market Cap: AU$204.1m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Pangaea Oncology

Market Cap: €56.4m

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

Galderma Group

Market Cap: CHF 40.5b

Operates as a dermatology company worldwide.

WuXi XDC Cayman

Market Cap: HK$76.1b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

AcrobiosystemsLtd

Market Cap: CN¥8.5b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

Chugai Pharmaceutical

Market Cap: JP¥12.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Selvita

Market Cap: zł554.3m

Provides drug discovery, drug development, and contract testing services in Poland.

Caliway Biopharmaceuticals

Market Cap: NT$167.3b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Travere Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

BioGaia

Market Cap: SEK 11.8b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Mesa Laboratories

Market Cap: US$527.0m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Mesoblast

Market Cap: AU$2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Sotera Health

Market Cap: US$5.2b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

hVIVO

Market Cap: UK£47.1m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BioLife Solutions

Market Cap: US$1.4b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

SIGA Technologies

Market Cap: US$251.0m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

ALK-Abelló

Market Cap: DKK 53.8b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

PharmaEssentia

Market Cap: NT$529.7b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Strides Pharma Science

Market Cap: ₹99.8b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.